EcoDrugPlus

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSSTUG00000049004
Gene Symbol: ATP1B1
3 Cross references
218 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSSTUG00000023906
Gene Symbol: ATP1B1
3 Cross references
224 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSSTUG00000005977
Gene Symbol: ATP1B1
3 Cross references
224 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSSTUG00000010029
Gene Symbol: ATR
3 Cross references
197 Possible Orthologues:

B1 Bradykinin Receptor-Like

Ensembl ID : ENSSTUG00000016796
Gene Symbol: LOC115162715
3 Cross references
144 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSSTUG00000028266
Gene Symbol: BCL2
3 Cross references
170 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSSTUG00000048173
Gene Symbol: BCL2
3 Cross references
170 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSSTUG00000034657
Gene Symbol: BCL2L1
3 Cross references
215 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSSTUG00000017701
Gene Symbol: BCL2L1
3 Cross references
215 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSSTUG00000035645
Gene Symbol: BCR
3 Cross references
199 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSSTUG00000017451
Gene Symbol: BCR
3 Cross references
198 Possible Orthologues:

Bdnf/nt-3 Growth Factors Receptor-Like

Ensembl ID : ENSSTUG00000003327
Gene Symbol: LOC115159210
3 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).